Literature DB >> 22676257

Effect of preparation conditions on the size and encapsulation properties of mPEG-PLGA nanoparticles simultaneously loaded with vincristine sulfate and curcumin.

Haiou Wang1, Yuntao Jia, Wenjing Hu, Huiming Jiang, Jingqing Zhang, Liangke Zhang.   

Abstract

This study prepared monomethoxy poly(ethylene glycol)-poly(lactide-co-glycolide) (mPEG-PLGA) nanoparticles simultaneously loaded with vincristine sulfate (Vin) and curcumin (Cur) via O/W emulsion solvent evaporation. Five independent processing parameters were systematically evaluated to enhance the entrapment of dual agents with different properties (i.e. Vin and Cur, which are the hydrophilic and hydrophobic, respectively) into mPEG-PLGA nanoparticles and to control the particle size. The approaches used to investigate the enhancement of drug entrapment efficiencies and control over the particle size included mPEG-PLGA concentration, polyvinyl alcohol (PVA) concentration, initial Vin/Cur content, dichloromethane-to-acetone volume ratio, and aqueous-to-organic phase volume ratio. The nanoparticles produced using the optimum formulation conditions had a particle size of 131.5 nm with a low polydispersity index of 0.047. The entrapment efficiencies were 63.52 ± 2.36% for Vin and 54.60 ± 2.46% for Cur (n = 3). The drug loadings were 1.06 ± 0.04% for Vin and 3.64 ± 0.16% for Cur (n = 3).

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22676257     DOI: 10.3109/10837450.2012.696267

Source DB:  PubMed          Journal:  Pharm Dev Technol        ISSN: 1083-7450            Impact factor:   3.133


  10 in total

1.  Novel lansoprazole-loaded nanoparticles for the treatment of gastric acid secretion-related ulcers: in vitro and in vivo pharmacokinetic pharmacodynamic evaluation.

Authors:  Milind Alai; Wen Jen Lin
Journal:  AAPS J       Date:  2014-02-12       Impact factor: 4.009

2.  Development and Characterization of PLGA Nanoparticle-Laden Hydrogels for Sustained Ocular Delivery of Norfloxacin in the Treatment of Pseudomonas Keratitis: An Experimental Study.

Authors:  Rana M Gebreel; Noha A Edris; Hala M Elmofty; Mina I Tadros; Mohamed A El-Nabarawi; Doaa H Hassan
Journal:  Drug Des Devel Ther       Date:  2021-02-05       Impact factor: 4.162

Review 3.  Thermosensitive Chitosan-β-Glycerophosphate Hydrogels as Targeted Drug Delivery Systems: An Overview on Preparation and Their Applications.

Authors:  Pouria Rahmanian-Devin; Vafa Baradaran Rahimi; Vahid Reza Askari
Journal:  Adv Pharmacol Pharm Sci       Date:  2021-05-05

4.  Polydopamine and peptide decorated doxorubicin-loaded mesoporous silica nanoparticles as a targeted drug delivery system for bladder cancer therapy.

Authors:  Yi Wei; Li Gao; Lu Wang; Lin Shi; Erdong Wei; Baotong Zhou; Li Zhou; Bo Ge
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

5.  Application of nanoparticles for oral delivery of acid-labile lansoprazole in the treatment of gastric ulcer: in vitro and in vivo evaluations.

Authors:  Milind Alai; Wen Jen Lin
Journal:  Int J Nanomedicine       Date:  2015-06-18

6.  Paclitaxel-loaded star-shaped copolymer nanoparticles for enhanced malignant melanoma chemotherapy against multidrug resistance.

Authors:  Yongsheng Su; Jian Hu; Zhibin Huang; Yubin Huang; Bingsheng Peng; Ni Xie; Hui Liu
Journal:  Drug Des Devel Ther       Date:  2017-03-06       Impact factor: 4.162

7.  Brain targeting stealth lipomers of combined antiepileptic-anti-inflammatory drugs as alternative therapy for conventional anti-Parkinson's.

Authors:  Iman M Higazy
Journal:  Saudi Pharm J       Date:  2019-11-13       Impact factor: 4.330

8.  PLGA nanoparticle preparations by emulsification and nanoprecipitation techniques: effects of formulation parameters.

Authors:  Karol Yesenia Hernández-Giottonini; Rosalva Josefina Rodríguez-Córdova; Cindy Alejandra Gutiérrez-Valenzuela; Omar Peñuñuri-Miranda; Paul Zavala-Rivera; Patricia Guerrero-Germán; Armando Lucero-Acuña
Journal:  RSC Adv       Date:  2020-01-27       Impact factor: 4.036

9.  Investigation of chitosan-g-PEG grafted nanoparticles as a half-life enhancer carrier for tissue plasminogen activator delivery.

Authors:  Arezoo Khosravi; Hadi Baharifar; Mohamad Hasan Darvishi; Ali Akbar Karimi Zarchi
Journal:  IET Nanobiotechnol       Date:  2020-12       Impact factor: 1.847

10.  Investigation and optimization of formulation parameters on preparation of targeted anti-CD205 tailored PLGA nanoparticles.

Authors:  Sheikh Tasnim Jahan; Azita Haddadi
Journal:  Int J Nanomedicine       Date:  2015-12-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.